Shukra Medtech Schedules Board Meeting to Approve Q2 Results
Shukra Pharmaceuticals Ltd 路 Intimation 路 03 Nov 2026, 5:30 am
Shukra Medtech Schedules Board Meeting to Approve Q2 Results Shukra Medtech Limited (formerly Shukra Pharmaceuticals Limited) has scheduled a Board of Directors meeting on 3rd Nov'26 at its registered office. The board will inter alia consider and approve the company's unaudited financial results for the second quarter and half-year ended 30th Sep'26, alongside the Auditor's Limited Review Report.
Original exchange filing (PDF)
More announcements from Shukra Pharmaceuticals Ltd
- Approval for Change of Name of Company on National Stock Exchange Limited dated 16th November 2026 路 17 Nov 2026
- Media Release 路 05 Nov 2026
- Shukra Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Reg 32 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- SHUKRA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 04 Nov 2026
- The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 路 04 Nov 2026
